97 related articles for article (PubMed ID: 70146)
1. [Study of antithrombin III in pancreatitis (author's transl)].
Uehara S; Hirayama A
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):248-54. PubMed ID: 70146
[No Abstract] [Full Text] [Related]
2. [Change in the trypsin-binding activity of alpha 2-macroglobulin and the general antitrypsin activity of the blood in chronic pancreatitis].
Chernoiarova OD; Loginov AS; Sadokov VM
Klin Med (Mosk); 1983 Nov; 61(11):88-91. PubMed ID: 6198558
[No Abstract] [Full Text] [Related]
3. [Studies on physiological inhibitors of coagulation and fibrinolysis in hepatobiliary diseases and acute pancreatitis (author's transl)].
Yoshimura R; Satake K
Rinsho Ketsueki; 1978 Jul; 19(7):927-33. PubMed ID: 81327
[No Abstract] [Full Text] [Related]
4. [Changes of antithrombin (antithrombin III, alpha2-macroglobulin) in various diseases (author's transl)].
Matsuda T; Ogawara M; Kodama N; Murakami M
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):261-6. PubMed ID: 70147
[No Abstract] [Full Text] [Related]
5. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
Campo G; Modena N; Gallo A; Ciaffoni S
Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
[TBL] [Abstract][Full Text] [Related]
6. [Effects of alpha2-macroglobulin and FDP on the antithrombin III assay system (author's transl)].
Yoshida N; Tachiya K; Moroi M; Matsuda M; Aoki N
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):197-201. PubMed ID: 70144
[No Abstract] [Full Text] [Related]
7. Proceedings: The relationship between antithrombin III, progressive antithrombin activity and anti Xa activity in plasma.
Whigham K; Howie PW; Forbes CD; Prentice CR
Thromb Diath Haemorrh; 1975 Sep; 34(1):365. PubMed ID: 52904
[No Abstract] [Full Text] [Related]
8. Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.
Harpel PC; Rosenberg RD
Prog Hemost Thromb; 1976; 3():145-89. PubMed ID: 59937
[No Abstract] [Full Text] [Related]
9. [Immunological assay of antithrombin (anthrombin III and alpha2-macroglobulin) (author's transl)].
Meguro T; Yamada K; Shirahata A
Rinsho Byori; 1975 Aug; 23(8):635-8. PubMed ID: 811830
[No Abstract] [Full Text] [Related]
10. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.
Lebreton de Vonne T; Mouray H
Int J Biochem; 1980; 12(3):479-84. PubMed ID: 6158467
[No Abstract] [Full Text] [Related]
11. [Antithrombin III and fibrinolysis during pregnancy and oral contraceptive therapy].
Laursen B; Herbst TV; Ewald EC; Pedersen SC
Ugeskr Laeger; 1976 Feb; 138(6):344-8. PubMed ID: 56073
[No Abstract] [Full Text] [Related]
12. [Studies on the interaction of human cationic trypsin with serum protease inhibitors (author's transl)].
Iwaki K; Ogawa M; Kitahara T; Tanaka S; Kosaki G
Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):276-81. PubMed ID: 6178863
[No Abstract] [Full Text] [Related]
13. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
Matsuda T
Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
[No Abstract] [Full Text] [Related]
14. Familial thrombosis due to antithrombin III deficiency in a Greek family.
Stathakis NE; Papayannis AG; Antonopoulos M; Gardikas C
Acta Haematol; 1977; 57(1):47-54. PubMed ID: 65891
[TBL] [Abstract][Full Text] [Related]
15. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
Walker ID; Davidson JF; Young P; Conkie JA
Thromb Diath Haemorrh; 1975 Sep; 34(1):106-14. PubMed ID: 52896
[TBL] [Abstract][Full Text] [Related]
16. [Plasma and serum antithrombin III levels in cerebrovascular patients (author's transl)].
Takamatsu S; Satoh K; Sakuta S; Mizuno S; Sugawara H
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):238-43. PubMed ID: 578069
[No Abstract] [Full Text] [Related]
17. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
[No Abstract] [Full Text] [Related]
18. [Clinical significance of the natural inhibitors to coagulation and fibrinolysis in cases of renal diseases (author's transl)].
Nakamura K; Kazama M
Rinsho Ketsueki; 1978 Jul; 19(7):934-9. PubMed ID: 81328
[No Abstract] [Full Text] [Related]
19. Measurement of antithrombin III, alpha 2-macroglobulin and alpha 1-antitrypsin in patients with deep venous thrombosis and pulmonary embolism.
de Boer AC; van Riel LA; den Ottolander GJ
Thromb Res; 1979; 15(1-2):17-25. PubMed ID: 90398
[No Abstract] [Full Text] [Related]
20. [Changes of antithrombin III in the thrombotic diathesis (author's transl)].
Oguri T; Kato R; Sugawara Y; Sugie I; Yamamoto H
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):244-7. PubMed ID: 578070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
